FDA Reviews Kidney Disease Drug From Apellis Pharmaceuticals - Apellis Pharmaceuticals ( NASDAQ:APLS )
The FDA granted Priority Review to Apellis' sNDA for Empaveli in C3G and IC-MPGN, with a PDUFA target action date of July 28, 2025. Phase 3 results showed Empaveli reduced proteinuria by 68% and stabilized kidney function ( p=0.03 ) in patients with C3G and IC-MPGN.
ATKR Investor Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Securities Fraud Class Action Lawsuit Filed Against Atkore Inc. ( ATKR ) - Atkore ( NYSE:ATKR )
RADNOR, Pa., April 01, 2025 ( GLOBE NEWSWIRE ) -- The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that securities class action lawsuits have been filed in the United States District Court for the Northern District of Illinois against Atkore Inc. ( "Atkore" ) ...
Looking At Microsoft's Recent Unusual Options Activity - Microsoft ( NASDAQ:MSFT )
Whales with a lot of money to spend have taken a noticeably bullish stance on Microsoft. Looking at options history for Microsoft MSFT we detected 170 trades. If we consider the specifics of each trade, it is accurate to state that 42% of the investors opened trades with bullish expectations and ...
Alphabet Is A Massive Cash Flow Machine With An Under-Leveraged Balance Sheet: Analyst - Alphabet ( NASDAQ:GOOGL )
WestPark Capital initiates coverage of Alphabet with a Buy rating and $210 price target, despite slight Q4 revenue miss. Alphabet's strong cash flow and AI potential position it well for growth, but slowing Google Cloud growth raises investor concerns. Feel unsure about the market's next move?
W.R. Berkley Nears Historical Price-To-Book High, Analyst Downgrades Stock On Overvaluation Concerns - WR Berkley ( NYSE:WRB )
BofA Securities downgraded W.R. Berkley to Neutral, citing limited upside despite strong fundamentals and high valuation. Analyst highlights Berkley's lower casualty volatility and strong ROE but sees limited growth potential at current stock price. Feel unsure about the market's next move?
SoftBank Weighs $16.5 Billion Loan That Could Back OpenAI's $40 Billion Raise: Report - SoftBank Group ( OTC:SFTBF ) , SoftBank Group ( OTC:SFTBY )
SoftBank considers a $16.5B loan to fund U.S. AI ambitions, including a potential $40B investment in OpenAI. SoftBank plans massive AI infrastructure project in the U.S., partnering with OpenAI, Oracle, and MGX.
Why Aptose Biosciences ( APTO ) Stock Is Down Over 40% - Aptose Biosciences ( NASDAQ:APTO )
Aptose Biosciences shares are trading lower by 53.7% during Tuesday's session. The company announced it is going to delist from the Nasdaq. The 'Trade of the Day' is now live. Get a high-probability setup with clear entry and exit points right here.
Transaction in Own Shares
Shell plc ( the 'Company' ) announces that on 01 April 2025 it purchased the following number of Shares for cancellation. Aggregated information on Shares purchased according to trading venue:
What's Going On With Quantum Computing Stock Today? - Quantum Computing ( NASDAQ:QUBT ) , SPDR S&P Software & Services ETF ( ARCA:XSW )
Quantum Computing Inc. secures its second order for Quantum Photonic Vibrometer from TU Delft for advanced sensing and monitoring. Despite securing a major order, QUBT stock drops 3.21%, following a 666% gain over the past year. The 'Trade of the Day' is now live.
What's Going On With PVH Shares Tuesday? - PVH ( NYSE:PVH )
PVH reported sales of $2.37 billion, beating analysts' estimate of $2.33 billion. The company announced plans to repurchase $500 million of its shares. Feel unsure about the market's next move? Copy trade alerts from Matt Maley-a Wall Street veteran who consistently finds profits in volatile ...


